About this trial
The International Severe Asthma Registry is a global initiative looking to ensure that the care of people with severe asthma will continue to improve by collecting detailed information about the health and treatment of as many people with the disease as possible. The study will gather anonymized longitudinal real-life data for participants with severe asthma for five years. The purpose of the registry is to track the progress of participants and determine how well they are responding to treatment. Medical research using data from the registry will give the investigators a better understanding of severe asthma and help the investigators develop and improve the care and treatment for severe asthma participants. The Canadian cohort of the registry will collect information from Canadian participants with severe asthma across seven different sites.
Eligibility criteria
Qualifiers
Participants 18 years or older
Participants receiving treatment according to GINA Step 5 or uncontrolled in GINA Step 4 (uncontrolled is defined as having severe asthma symptoms or frequent exacerbations)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
University of Alberta
Collaborator
University of Toronto
Collaborator
Laval University
Collaborator
McGill University
Collaborator
Université de Sherbrooke
Collaborator
The Ottawa Hospital
Collaborator
Kingston Health Sciences Centre
Collaborator
University of Saskatchewan
Collaborator
Western University, Canada
Collaborator